Market News AIOpen the app

Theriva Biologics will do a reverse stock split on December 1, 2026, to meet NYSE American rules.

New sharesRead the original at SEC EDGAR
Neutral

Theriva will combine 30 shares into 1 to meet NYSE American's per-share price rules. This may support its listing, but it adds no cash or changes its drug programs, leaving the company's outlook unchanged.

TOVX · Theriva Biologics, Inc.

AI read · Neutral

The AI's read

That could help Theriva meet NYSE American's per-share price rules and support its listing. But the share count and authorized share count both shrink proportionally, and no cash is raised. The filing reports no change to its drug programs, so the listing benefit does not show a broader business change.

Get alerts for TOVX

Follow Theriva Biologics, Inc. (TOVX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TOVX
Free on the App Store and Google Play, or on the web.